S. Rutella et al., Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression, EXP HEMATOL, 28(6), 2000, pp. 612-625
Objective. Sera from healthy subjects receiving recombinant human granulocy
te colony-stimulating factor (rHuG-CSE) to mobilize CD34(+) peripheral bloo
d progenitors (PBPC) have been recently shown to induce unresponsiveness of
allogeneic lymphocytes to mitogenic challenge. In the present investigatio
n, the effects of rHuG-CSF on the early stages-of lymphocyte activation-ind
uced apoptosis and on lymphocyte cell cycle entry were evaluated.
Materials and Methods. Sera were obtained from HLA-identical donors receivi
ng rHuG-CSF to mobilize CD34(+) PBPC for allogeneic transplantation. Normal
peripheral blood mononuclear cells (PBMC) were challenged with phytohemagg
lutinin (PHA) in the presence of serum collected before (preG) or after rHu
G-CSF administration (postG), Mitochondrial function, that is, incorporatio
n of 3,3'-dihexyloxacarbocyanine iodide [DiOC(6)(3)] and generation of reac
tive oxygen species (ROS) as well as expression of c-Myc and Bcl-2 family m
embers (Bcl-2, Bcl-X-L, Bax) were evaluated by multiparameter flow cytometr
y. The activation-induced fragmentation of genomic DNA was detected by high
ly sensitive LM-PCR assay.
Results. CD4(+)DiOC(6)(3)(low) and CD8(+)DiOC(6)(3)(low) T lymphocytes incr
eased and reached 32% (range 27%38%) and 20% (range 15%-23%) of circulating
T cells, respectively, on day 4 of rHuG-CSF administration. Hypergeneratio
n of ROS could be demonstrated in 65% (range 58%-82%) of CD4(+) T lymphocyt
es and in 0.4% (range 0.2%-0.8%) of circulating CD8(+) T cells. rHuG-CSF de
termined no alteration of mitochondrial function if added to allogeneic PBM
C in vitro, thus suggesting indirect effects mediated by soluble factors; o
n the contrary, when PBMC were challenged with PHA in the presence of postG
serum, both perturbation of mitochondrial transmembrane potential (Delta p
si(m)) and hypergeneration of ROS were induced, and lymphocytes were predom
inantly arrested in a G(o)-like phase of the cell cycle and displayed genom
ic DNA fragmentation. Interestingly, the preincubation of PBMC with a block
ing antibody directed against CD95 abrogated the perturbation of lymphocyte
Delta psi(m), suggesting that the CD95 signaling pathway might play a role
in the induction of apoptosis after PHA stimulation in the presence of pos
tG serum. Moreover, Bar protein was overexpressed in postG (median fluoresc
ence intensity = 180, range 168-186) compared with preG cultures (median fl
uorescence intensity = 75, range 68-80; p < 0.01), while no differences in
Bcl-2, Bcl-X-L, and c-Myc staining intensity were observed.
Conclusions. Our findings demonstrate a humoral-mediated rHuG-CSF-induced d
issipation of lymphocyte mitochondrial Delta psi(m); these effects might he
mediated by Pax overexpression, with imbalance between apoptosis-promoting
and apoptosis-inhibiting Bcl-2 family members and with subsequent inductio
n of mitochondrial permeability transition. Whether immune dysfunction will
favorably impact on incidence and severity of acute graft vs host disease
after allogeneic PBPC transplantation remains to be determined. (C) 2000 in
ternational Society for Experimental Hematology. Published by Elsevier Scie
nce Inc.